News
ADPT ▲ +2.2% - Adaptive Biotechnologies Corporation
ADPT ▲ +2.2% - Adaptive Biotechnologies Corporation
$ADPT - Adaptive Biotechnologies Highlights clonoSEQ’s Central Role in Advancing MRD-Guided Care Across Hematology at ASH 2026
18-NOV-2026 03:00 AM ET
Share this post
More filings for $ADPT
ADPT ▼ -2.9% - Adaptive Biotechnologies CorporationNov 10, 2026ADPT ▲ +10.4% - Adaptive Biotechnologies CorporationNov 4, 2026ADPT ▲ +11.7% - Adaptive Biotechnologies CorporationNov 4, 2026ADPT ▲ +1.3% - Adaptive Biotechnologies CorporationOct 14, 2026ADPT ▲ +1.0% - Adaptive Biotechnologies CorporationSep 25, 2026ADPT ▲ +1.2% - Adaptive Biotechnologies CorporationSep 17, 2026
View full $ADPT filing history →💬 Comments
Loading comments…
Leave a comment
